Sequana Medical NV
XBRU:SEQUA

Watchlist Manager
Sequana Medical NV Logo
Sequana Medical NV
XBRU:SEQUA
Watchlist
Price: 0.986 EUR -1.2% Market Closed
Market Cap: 51.7m EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+345%
Revenue
Forecast
+175%
Operating Income
Forecast
+19%
Net Income
Forecast
+17%

Wall Street
Price Targets

SEQUA Price Targets Summary
Sequana Medical NV

Wall Street analysts forecast SEQUA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SEQUA is 4.386 EUR with a low forecast of 2.929 EUR and a high forecast of 5.25 EUR.

SEQUA Lowest Forecast
Wall Street Target
2.929 EUR
197% Upside
SEQUA Average Forecast
Wall Street Target
4.386 EUR
345% Upside
SEQUA Highest Forecast
Wall Street Target
5.25 EUR
432% Upside
Lowest
Price Target
2.929 EUR
197% Upside
Average
Price Target
4.386 EUR
345% Upside
Highest
Price Target
5.25 EUR
432% Upside
Sequana Medical NV Competitors:
Price Targets
1789
AK Medical Holdings Ltd
5% Upside
IDXX
IDEXX Laboratories Inc
26% Upside
AFX
Carl Zeiss Meditec AG
5% Downside
7575
Japan Lifeline Co Ltd
13% Upside
1789
AK Medical Holdings Ltd
5% Upside
IDXX
IDEXX Laboratories Inc
26% Upside
AFX
Carl Zeiss Meditec AG
5% Downside
7575
Japan Lifeline Co Ltd
13% Upside
B
301367
BMC Medical Co Ltd
1% Upside
S
STXS
Stereotaxis Inc
164% Upside
6869
Sysmex Corp
21% Upside
LMAT
LeMaitre Vascular Inc
30% Upside

Revenue
Forecast

Revenue Estimate
Sequana Medical NV

For the last 7 years the compound annual growth rate for Sequana Medical NV's revenue is -10%. The projected CAGR for the next 3 years is 175%.

-10%
Past Growth
175%
Estimated Growth
Estimates Accuracy
-25%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Sequana Medical NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Sequana Medical NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-65%
Average Miss
What are analyst estimates?

See Also

Summary
SEQUA intrinsic value, competitors valuation, and company profile.
DCF Valuation
SEQUA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SEQUA stock valuation using valuation multiples.
Wall Street Estimates
SEQUA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SEQUA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SEQUA's stock price target?
Price Target
4.386 EUR

According to Wall Street analysts, the average 1-year price target for SEQUA is 4.386 EUR with a low forecast of 2.929 EUR and a high forecast of 5.25 EUR.

What is Sequana Medical NV's Revenue forecast?
Projected CAGR
175%

For the last 7 years the compound annual growth rate for Sequana Medical NV's revenue is -10%. The projected CAGR for the next 3 years is 175%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.